IOL Chemicals and Pharmaceuticals Ltd has received a Certificate of Suitability for company's API product "antoprazole Sodium Sesquihydrate Process-III from European Directorate for the Quality of Medicines & Health Care (EDQM).

Pantoprazole sodium is a proton pump inhibitor (PPI) that reduces stomach acid and is used to treat conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome.